[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370339-105":59,"doc-detail-370339-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-comprehensive-analysis-revealing-bub1b-as-a-potential-prognostic-and-immunological-biomarker-in-lung-adenocarcinoma","A Comprehensive Analysis Revealing BUB1B as a Potential Prognostic and Immunological Biomarker in Lung Adenocarcinoma","","BUB1B, a spindle assembly checkpoint kinase, has been linked to tumor progression, yet its role in cancer development remains insufficiently defined. This study performs a systematic pan-cancer and lung adenocarcinoma-focused analysis using multiple public databases. BUB1B expression is evaluated for associations with patient prognosis, immune cell infiltration, and immunomodulatory genetic markers, and is tested functionally in LUAD through proliferation and migration assays with Western blot verification. Results show widespread upregulation, prognostic relevance, and immune pathway involvement, supporting BUB1B as a biomarker and therapeutic candidate.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-comprehensive-analysis-revealing-bub1b-as-a-potential-prognostic-and-immunological-biomarker-in-lung-adenocarcinoma/370339/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-comprehensive-analysis-revealing-bub1b-as-a-potential-prognostic-and-immunological-biomarker-in-lung-adenocarcinoma/370339.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of this study?","Question",{"text":112,"@type":113},"To systematically analyze BUB1B’s role in cancer progression, with a particular focus on lung adenocarcinoma, and to evaluate its potential as a prognostic and immunological biomarker.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was BUB1B assessed across cancers?",{"text":117,"@type":113},"BUB1B expression and clinical associations were analyzed using TCGA data and multiple bioinformatics platforms, including HPA, TIMER, TISIDB, GEPIA, cBioPortal, GDC, LinkedOmics, and CancerSEA.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental evidence supports BUB1B’s role in lung adenocarcinoma?",{"text":121,"@type":113},"BUB1B was functionally tested in lung cancer cells using siRNA knockdown, which inhibited proliferation and migration in vitro, supported by assays including CCK-8, wound healing, transwell, and Western blot analysis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370339,1790317236,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nA Comprehensive Analysis Revealing BUB1B as a Potential Prognostic and Immunological Biomarker in  \nLung Adenocarcinoma  \nZhenzhen Hao, Fei An, Wanting Zhang, Xiaoshuang Zhu, Shihao Meng and Bo Zhao *  \nInstitute of Biochemistry and Molecular Biology, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China; [1710065@stu.neu.edu.cn](1710065@stu.neu.edu.cn) (Z.H.); [2201435@stu.neu.edu.cn](2201435@stu.neu.edu.cn) (F.A.);  \n[2110482@stu.neu.edu.cn](2110482@stu.neu.edu.cn) (W.Z.); [2010494@stu.neu.edu.cn](2010494@stu.neu.edu.cn) (X.Z.); [2310514@stu.neu.edu.cn](2310514@stu.neu.edu.cn) (S.M.)  \n* Correspondence: [1810068@stu.neu.edu.cn](1810068@stu.neu.edu.cn); Tel.: +86-24-8365-6125  \nAcademic Editor: Francesca Bersani  \nReceived: 20 December 2024  \nRevised: 17 January 2025  \nAccepted: 11 February 2025  \nPublished: 26 February 2025  \nCitation: Hao, Z.; An, F.; Zhang, W.; Zhu, X.; Meng, S.; Zhao, B. A Comprehensive Analysis Revealing BUB1B as a Potential Prognostic and Immunological Biomarker in Lung Adenocarcinoma. Int. J. Mol. Sci. 2025, 26, 2061. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms26052061  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \nAbstract: BUB1B, a member of the spindle assembly checkpoint family known as BUB1 mitotic checkpoint serine/threonine kinase B, has been associated with the promotion of tumor progression. Nevertheless, its specific contributions to tumorigenesis remain largely unexplored. This study seeks to offer a systematic and comprehensive analysis of the role of BUB1B in the progression of various cancers, with a particular focus on lung adenocarcinoma, utilizing a range of databases. We investigated BUB1B’s role in pan-cancer using TCGA data, analyzing it with platforms like HPA, TIMER, TISIDB, GEPIA, cBioPortal, GDC, LinkedOmics, and CancerSEA. Additionally, we assessed BUB1B’s impact on lung adenocarcinoma proliferation and migration through CCK-8, wound healing, transwell assays and Western blot analysis. This study found that BUB1B was upregulated in most cancers and was significantly linked to patient prognosis. Its expression correlated with immune cell infiltration and genetic markers of immunomodulators across different cancers. BUB1B was involved in the acute inflammatory response and IgA production pathways but negatively correlated with inflammation in lung adenocarcinoma. Moreover, the siRNAmediated knockdown of BUB1B resulted in the inhibition of proliferation and migration of lung cancer cells in vitro. This study underscores the potential of BUB1B as a biomarker and a promising therapeutic target for patients with lung adenocarcinoma.  \nKeywords: pan-cancer; BUB1B; immune microenvironment; prognosis; LUAD; biomarker  \n1. Introduction  \nIn contemporary times, cancer poses a significant threat to public health. Despite substantial advancements in cancer treatment modalities such as surgery, chemotherapy, and radiotherapy, the 5-year overall survival (OS) rate for patients remains suboptimal. In recent years, immunotherapy has achieved considerable success in cancer treatment, exemplified by the clinical efficacy of immune checkpoint inhibitors [1–4] . Furthermore, the rapid advancement of the TCGA database has facilitated more comprehensive analyses of the correlation and impact of individual genes on cancer prognosis and immune infiltration. Consequently, there is a pressing need to identify novel diagnostic and prognostic biomarkers for cancer. Additionally, the significant success of immunotherapy has underscored the importance of immune-related biomarkers.  \nCancer immunotherapy, which utilizes the immune system t","cbCairMxva2JXxTc","https://ap.wps.com/l/cbCairMxva2JXxTc","pdf",5168751,16,"English","# 1. Introduction\n## Cancer immunotherapy and tumor microenvironment\n## Lung adenocarcinoma and immunotherapy challenges\n## Rationale for identifying biomarkers\n# 2. Materials and Methods\n## Pan-cancer database analyses\n## Lung adenocarcinoma validation and functional assays\n# 3. Results\n## BUB1B expression patterns and prognostic links\n## Correlation with immune infiltration and immunomodulators\n## Pathway associations and inflammation findings\n## BUB1B knockdown effects in vitro\n# 4. Discussion","[{\"question\":\"What was the main objective of this study?\",\"answer\":\"To systematically analyze BUB1B’s role in cancer progression, with a particular focus on lung adenocarcinoma, and to evaluate its potential as a prognostic and immunological biomarker.\"},{\"question\":\"How was BUB1B assessed across cancers?\",\"answer\":\"BUB1B expression and clinical associations were analyzed using TCGA data and multiple bioinformatics platforms, including HPA, TIMER, TISIDB, GEPIA, cBioPortal, GDC, LinkedOmics, and CancerSEA.\"},{\"question\":\"What experimental evidence supports BUB1B’s role in lung adenocarcinoma?\",\"answer\":\"BUB1B was functionally tested in lung cancer cells using siRNA knockdown, which inhibited proliferation and migration in vitro, supported by assays including CCK-8, wound healing, transwell, and Western blot analysis.\"}]","A Comprehensive Analysis Revealing BUB1B as a Potential Prognostic and Immunological Biomarker in Lung Adenocarcinoma | PDF",1790188116,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4576633fbd81f803b57d3e8a1646227a.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8952c85539b283b33f11dfaf1994cd7f.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d1aa3128d168c41cf77979d39bb6d7a.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4add4f3f7dd0d995e1e4631ed2fa6180.webp",980,1385]